Glycosylation of HIV-1 gp120 V3 Loop: Towards the Rational Design of a Synthetic Carbohydrate Vaccine

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|14|30|3232-3242

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.14, Iss.30, 2007-12, pp. : 3232-3242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV-1 gp120: A Target for Therapeutics and Vaccine Design

By  

Current Drug Targets, Vol. 17, Iss. 1, 2016-01 ,pp. : 122-135

Bentham Science Publishers

Access to resources Recommend Favorite

Conformational Properties of HIV-1 gp120/V3 Immunogenic Domains

By  

Current Medicinal Chemistry, Vol. 12, Iss. 13, 2005-06 ,pp. : 1551-1568

Bentham Science Publishers

Access to resources Recommend Favorite

Human immunodeficiency virus-1 gp120 V3 loop for anti-acquired immune deficiency syndrome drug discovery: computer-aided approaches to the problem solving

By Andrianov Alexander M  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 4, 2011-04 ,pp. : 419-435

Informa Healthcare

Access to resources Recommend Favorite

Entry Inhibitors Directed Towards Glycoprotein gp120: An Overview on a Promising Target for HIV-1 Therapy

By  

Current Medicinal Chemistry, Vol. 20, Iss. 6, 2013-01 ,pp. : 751-771

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Cations in the Interaction of Pradimicins with HIV-1 Envelope gp120

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 16, 2013-08 ,pp. : 1907-1915

Bentham Science Publishers

Access to resources Recommend Favorite